Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions (DDI+)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Leumit Health Services
ClinicalTrials.gov Identifier:
NCT01765595
First received: January 9, 2013
Last updated: October 20, 2014
Last verified: October 2014
  Purpose

Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).


Condition Intervention
Healthcare
Other: DDI+

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research

Resource links provided by NLM:


Further study details as provided by Leumit Health Services:

Primary Outcome Measures:
  • Hospital Admissions [ Time Frame: up to 12 months post initiation ] [ Designated as safety issue: Yes ]

Enrollment: 715
Study Start Date: January 2013
Study Completion Date: October 2014
Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: DDI+
DDI+ Incorporated in routine ambulatory practice
Other: DDI+
No Intervention: Control
Standard care

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Number of chronic concomitant drugs ≥5

Exclusion Criteria:

  • Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01765595

Locations
Israel
Leumit Health Services
Tel-Aviv, Israel
Sponsors and Collaborators
Leumit Health Services
Investigators
Principal Investigator: Abraham Weizman, MD Tel Aviv University
  More Information

No publications provided

Responsible Party: Leumit Health Services
ClinicalTrials.gov Identifier: NCT01765595     History of Changes
Other Study ID Numbers: LHS012013
Study First Received: January 9, 2013
Last Updated: October 20, 2014
Health Authority: Israel: Ministry of Health

Keywords provided by Leumit Health Services:
health care expenditure
drug drug interactions
electronic decision support systems
Potential reduction

ClinicalTrials.gov processed this record on October 23, 2014